MedTrace Logo

European Post-Market Study for Medial Knee Osteoarthritis Treated With the Atlas Knee System for Load Reduction

NCT02663414 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2019-03-21

No results posted yet for this study

Summary

The objective of this study is to collect post market data on safety and performance of the Atlas Knee System in patients with osteoarthritis (OA) of the medial knee compartment through a 24 months post-operative follow-up period.

Conditions

  • Osteoarthritis (OA) of the Medial Knee Compartment

Interventions

DEVICE

Atlas Knee System

The Atlas Knee System is an approved device (CE Marked) and is an extra-capsular knee implant specifically designed to treat patients with uni-compartmental, medial knee osteoarthritis (OA).

Sponsors & Collaborators

  • Moximed

    lead INDUSTRY

Principal Investigators

  • Tessa Yamut · Moximed

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-11-30
Completion
2018-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02663414 on ClinicalTrials.gov